Diabetes Research

Share this
IMRIC Lead Researcher: 
Partner Lead Researcher: 
Dr. James Shapiro, Director, Clinical Islet Transplant Program University of Alberta, Edmonton
IMRIC Location: 
IMRIC, the Hebrew University of Jerusalem
Partner Location(s): 
University of Alberta, Edmonton, AB
Research Team(s)
IMRIC
Ben Glaser (Hadassah)
Gideon Zamir (Hadassah)
Areej Al-Khatib (Bet-Lehem)
Harry Heimberg (Brussels)
Doug Melton (Harvard)
Klaus Kaestner (Upenn)
Dr. James Shapiro (Edmonton)

This IMRIC collaboration partners Hebrew University's Yuval Dor with the University of Alberta's James Shapiro, Director of the Clinical Islet Transplant Program.

Diabetes occurs when beta cells in the pancreas produce insufficient insulin. Dr. Shapiro, a leading figure in the clinical treatment of diabetes, designed the Edmonton Protocol for transplanting insulin-producing beta cells into the pancreas of a diabetes sufferer. Prof. Dor's research at IMRIC determined that by eliminating a specific gene, called LKB1, from the beta cell, we can increase production and secretion of more insulin.

This IMRIC collaboration could pave the way for radical new diabetes treatment.  

Collaboration Partners

University of Alberta

This IMRIC collaboration partners Hebrew University's Prof. Yuval Dor with the University of Alberta's Dr. James Shapiro, Director of the Clinical Islet Transplant Program.